nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Lupin Limited (NSE India Code : LUPIN) BUY

Company Name :

Enter Company Name or NSE Code

LUPIN Technical Levels

Resistance 2		606.53
Resistance 1		602.07
PIVOT		597.53
Support 1		593.07
Support 2		584.07

LUPIN Fundamentals

Earning Growth		65.11%
Profit Margin		17.13
PE		30.40
EPS		18.63
Quarter		30-Sep-11

LUPIN Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size		500

LUPIN Options

Most Active Call		600
Most Active Put		560
Highest OI Call		600
Highest OI Put		560
Expiry Date		19-Oct-12

LUPIN Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

LUPIN Share Price on 5-10-2012

Open		582
High		583.85
Low		496.4
Close		568.15
Volume		1665476
Change		-11.05 (-1.91%)

Series		EQ
Date of Listing		10-Sep-01
Paid Up Value		2
Face Value		2
Market Capital		13483.2 Crores
52 Week High/Low		631.95 / 408.2

Sponsored Advertisement

Lupin Limited Company Profile

Lupin came into existence following the amalgamation of Lupin laboratories with Lupin Chemicals. Its activities include pharmaceuticals, bulk drugs and formulations, fermentation, bio-technology, natural products and agro chemicals. Its Lupin division offers solutions in the respiratory segment that covers anti-TB, anti-asthma (inhalation segment), anti-infectives, anti-allergies and supportive therapy products. The top six products in the API basket viz., cephalexin and cefaclor (anti-lnfectives), 7ADCA and 7ACCA (cephalosporin intermediates), ethambutol and rifampicin (anti-TB) cover nearly 80% of API sales to the semi regulated markets. Lisinopril (cardiovascular) forms the core API sales to the regulated markets. The biggest brand of the company is R-Cinex. The Lupin division dominates the anti-TB segment with a market share of 45%. Its finished dosages business has outperformed the market growth rate by nearly two-and-half times. The company filed for 14 ANDAs and 15 DMFs and now has four molecules in clinical trials. It raised its R&D expenditure to 7.2% of net sales in 2004-2005 to create commercially viable intellectual property for the company. Its AKT-4 now occupies a 7.5% market share in the 4-drug combipack segment. Lupin has set its focus on broad-spectrum anti-bacterials, anti-asthma and diabetic research. The company has plans to enter new non-conventional route of drug administration. Synthesis of drugs involving complex chemistry/technology has been identified for process development research. New herbal leads for new indications have been identified for further development. It also plans to tap emerging opportunities for licensing-out products.

LUPIN Intraday Realtime Chart

LUPIN Corporate Announcements

DATE	PURPOSE
03-Aug-12	Allotment of Securities
02-Aug-12	Disclosure under Insider Trading Regulation
01-Aug-12	Disclosure under Insider Trading Regulation
27-Jul-12	Proceedings of Annual General Meeting
26-Jul-12	ESOPs/ESOS

LUPIN Corporate Actions

DATE	PURPOSE
13-Jul-12	Annual General Meeting And Dividend Rs.3.20 Per Share
13-Jul-12	AGM/DIV-RS.3.20 PER SHARE
18-Jul-11	Annual General Meeting And Dividend Rs.3/- Per Share
18-Jul-11	AGM/DIV-RS.3/- PER SHARE

LUPIN Board Meetings

MEETING DATE	PURPOSE
24-Jul-12	Un-audited Financial Results
10-May-12	Audited Financial Results
24-Jan-12	Un-audited Financial Results
09-Nov-11	Un-audited Financial Results
27-Jul-11	Un-audited Financial Results

LUPIN Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

Can I know the number of shares that would be allotted to me?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer